Harry Jansen Kraemer Net Worth

The estimated Net Worth of Harry M Jansen Jr Kraemer is at least $3.23 Milión dollars as of 2 May 2024. Mr. Kraemer owns over 4,788 units of Option Care Health stock worth over $2,888,378 and over the last 21 years he sold OPCH stock worth over $0. In addition, he makes $344,500 as Independent Non-Executive Chairman of the Board at Option Care Health.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Kraemer OPCH stock SEC Form 4 insiders trading

Harry has made over 17 trades of the Option Care Health stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 4,788 units of OPCH stock worth $252,328 on 2 May 2024.

The largest trade he's ever made was buying 60,000 units of Option Care Health stock on 30 July 2003 worth over $1,653,600. On average, Harry trades about 2,987 units every 52 days since 2003. As of 2 May 2024 he still owns at least 89,065 units of Option Care Health stock.

You can see the complete history of Mr. Kraemer stock trades at the bottom of the page.

Harry Jansen Kraemer biography

Harry M. Jansen Kraemer Jr. serves as Independent Non-Executive Chairman of the Board of the Company. He served on the legacy Option Care board from 2015 until the Merger. Mr. Kraemer is an Executive Partner of MDP where he has served since 2005, and has served as Clinical Professor of Management & Strategy at Northwestern University’s Kellogg School of Management since 2005. Mr. Kraemer was the Chairman, President and Chief Executive Officer of Baxter International Inc., a healthcare company, until 2004. Mr. Kraemer had been a Director of Baxter International since 1995, Chairman of the Board since 2000, President since 1997 and Chief Executive Officer since 1999. Mr. Kraemer has served on the Board of Directors of Leidos Holdings, Inc., a publicly traded defense, aviation, informational technology and biomedical research company, since 1997 and Dentsply Sirona Inc., a publicly traded dental equipment company, since 2016. Mr. Kraemer served on the board of directors of VWR Corporation, which became a publicly-traded company in 2014, from 2007 to 2017. Mr. Kraemer serves on the board of trustees of Northwestern University, the Conference Board and NorthShore University HealthSystem. Mr. Kraemer holds an M.B.A. from Northwestern University’s Kellogg School of Management and a bachelor’s degree in mathematics and economics from Lawrence University, and is a certified public accountant. Mr. Kraemer’s extensive experience with boards of private and public companies, investment decisions, capital allocation and complex transactions at both large companies and in private equity make him a valuable member of our Board.

What is the salary of Harry Kraemer?

As the Independent Non-Executive Chairman of the Board of Option Care Health, the total compensation of Harry Kraemer at Option Care Health is $344,500. There are 11 executives at Option Care Health getting paid more, with Harriet Booker having the highest compensation of $1,393,652.

How old is Harry Kraemer?

Harry Kraemer is 65, he's been the Independent Non-Executive Chairman of the Board of Option Care Health since 2019. There are 1 older and 20 younger executives at Option Care Health. The oldest executive at Option Care Health, Inc. is John Arlotta, 70, who is the Independent Director.

Insiders trading at Option Care Health

Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten a Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.

What does Option Care Health do?

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Complete history of Mr. Kraemer stock trades at DENTSPLY Sirona Inc, Baxter International, Leidos Inc a Option Care Health

Option Care Health executives and stock owners

Option Care Health executives and other stock owners filed with the SEC include:

• Harriet Booker,
  Chief Operating Officer
• Harriet Booker,
  Chief Operating Officer
• Rich Denness,
  Chief Strategy Officer
• John Rademacher,
  Chief Executive Officer, Director
• John C. Rademacher,
  CEO, Pres & Director
• Michael Shapiro,
  Chief Financial Officer
• Michael H. Shapiro,
  CFO & Sr. VP
• R. Carter Pate,
  Independent Director
• Clifford Berman,
  General Counsel
• Richard P. Denness,
  Chief Commercial Officer
• Clifford E. Berman,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Harry Jansen Kraemer,
  Independent Non-Executive Chairman of the Board
• David Golding,
  Independent Director
• John Arlotta,
  Independent Director
• Nitin Sahney,
  Independent Director
• Timothy Sullivan,
  Director
• Elizabeth Betten,
  Director
• Mark Vainisi,
  Director
• Alan Nielsen,
  Director
• Christopher Hartman,
  Chief Growth Officer
• Luke Whitworth,
  Sr. VP of Revenue Cycle Management
• Julie Koenig,
  Sr. VP of Operations
• Christopher Frederick Hartman,
  Chief Growth Officer
• Matthew Deans,
  Sr. VP of Bus. Devel.
• Michael W. Rude,
  Sr. VP & Chief HR Officer
• Cari Reed,
  Sr. VP & Chief Compliance Officer
• Brett Michalak,
  Chief Information Officer
• Robert R. Kampstra,
  Sr. VP of Fin. & Chief Accounting Officer
• Femi Adewunmi,
  Chief Medical Officer
• Barbara W. Bodem,
  Director
• Norman L. Wright,
  Director
• Boots Alliance, Inc.Och Us ...,
  
• Dearborn Partners Llcmadiso...,
  
• Dearborn Capital Partners V...,
  
• Elizabeth D Bierbower,
  Director
• Collin Smyser,
  GC & Corporate Secretary
• Natasha Deckmann,
  Director
• Seema Kumbhat,
  Chief Medical Officer
• Dearborn Partners Llcmadiso...,
  
• Robert R Kampstra,
  CHIEF ACCOUNTING OFFICER
• Dearborn Partners Llcmadiso...,
  
• Luke Whitworth,
  Chief Operating Officer
• Michael Bavaro,
  Chief Human Resources Officer
• Christopher L. Grashoff,
  Chief Growth Officer
• Eric Brandt,
  Director